Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Neutron scattering studies of the isolated C1r2C1s2 subunit of first component of human complement in solutionJ Boyd, D R Burton, S J Perkins, et al.
Journal of Virology|November 17, 2001
Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodiesM B Zwick, M Wang, P Poignard, et al.
Nature Medicine|December 13, 1997
Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1M C Gauduin, P W Parren, R Weir, et al.
Journal of Molecular Biology|December 1, 1995
CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar rangeW P Yang, K Green, S Pinz-Sweeney, et al.
Nucleic Acids Research|October 1, 1978
The interaction of core histones with DNA: equilibrium binding studiesD R Burton, M J Butler, J E Hyde, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1993
Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial librariesR A Williamson, R Burioni, P P Sanna, et al.
Journal of Virology|April 1, 1996
Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin moleculesM C Gauduin, G P Allaway, P J Maddon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Human autoantibody recognition of DNAS M Barbas, H J Ditzel, E M Salonen, et al.
Molecular Immunology|June 1, 1996
Characterization by serial deletion competition ELISAs of HIV-1 V3 loop epitopes recognized by monoclonal antibodiesS J Seligman, J M Binley, M K Gorny, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected miceJ E Crowe, B R Murphy, R M Chanock, et al.
Pageof 17